共 8 条
- [1] Associationofglycaemiawithmacrovascu larandmicrovascularcomplicationsofType2diabetes:prospectiveobservationalstudy (UKPDS 35). StrattonIM,AdlerAI,NeilHAW,MatthewsDR,ManleySE,CullCA,HaddenD,TurnerRC,HolmanRR. British Medical Journal . 2000
- [2] Lessnocturnalhypoglycemiaandbetterpost dinnerglucosecontrolwithbedtimeinsulinglarginecomparedwithbedtimeNPHinsulinduringinsulincombinationtherapyintype2diabetes. HOE 901/3002StudyGroup. Diabetes Care . 2000
- [3] Overviewofsixyears’therapyoftype2diabetes aprogressivedisease (UKPDS 16). UKPDSStudyGroup. Dia betesCare . 1995
- [4] Glycemiccon trolwithdiet,sulfonylurea,metformin,orinsulinin pa tientswithtype2diabetesmellitus:progressiverequirementformultipletherapies (UKPDS 49)UKProspectiveDiabetesStudy (UKPDS)Group. TurnerRC,CullCA,FrighiV,HolmanRR. The Journal of The American Medical Association . 1999
- [5] Endocrine review. MatthaeiS. .
- [6] Sulfonylurea Inadequacy : Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study(UKPDS 57). Wright A,Burden ACF,Paisey RB. Diabetes Care . 2002
- [7] Insulin Glargine4002Study In-vestigators The treat-to-target trial:randomized addition of glargine or human NPHinsulin to oral therapy of type2diabetic patients. Riddle MC,Rosenstock J,Gerich J. Diabetes Care . 2003
- [8] Relationofglycemiccontroltodiabeticmicrovascularcomplica tionsindiabetesmellitus. KleinR,KleinBE,MossSE. Annals of Internal Medicine . 1996